MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 5 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding MoonLake Immunotherapeutics changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 43 | 45 | +2 |
| Shares | 11.2M | 11.4M | +206.7K (+1.8%) |
| Value | $111.1M | $112.8M | +$1.75M (+1.6%) |
New holders (14)
Institutions that held MoonLake Immunotherapeutics at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| FMR LLC | 1,193,000 | $11.8M | 0.00% |
| Marshall Wace, LLP | 532,904 | $5.27M | 0.01% |
| Credit Suisse AG | 371,849 | $3.68M | 0.00% |
| Falcon Edge Capital, LP | 307,835 | $3.04M | 0.34% |
| Tenor Capital Management Co., L.P. | 201,152 | $1.99M | 0.04% |
| Cowen Investment Management LLC | 200,000 | $1.98M | 0.43% |
| Omni Event Management Ltd | 100,913 | $998.0K | 0.06% |
| Cohen & Co Financial Management, LLC | 100,000 | $989.0K | 0.66% |
| Jefferies Group LLC | 78,308 | $774.5K | 0.01% |
| Iron Park Capital Partners, LP | 62,216 | $615.0K | 0.49% |
| Schonfeld Strategic Advisors LLC | 50,106 | $496.0K | 0.00% |
| Weiss Asset Management LP | 15,000 | $148.0K | 0.00% |
| Rpo LLC | 13,600 | $135.0K | 0.05% |
| Antara Capital LP | 6,246 | $62.0K | 0.01% |
Sold out (12)
Institutions that held MoonLake Immunotherapeutics at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| RTW Investments, LP | 750,000 | $7.39M |
| Ra Capital Management, L.P. | 700,000 | $6.96M |
| Ghost Tree Capital, LLC | 500,000 | $4.94M |
| Wellington Management Group LLP | 483,887 | $4.78M |
| Finepoint Capital LP | 382,400 | $3.77M |
| Bain Capital Life Sciences Investors, LLC | 250,000 | $2.49M |
| Foresite Capital Management V, LLC | 250,000 | $2.49M |
| Rock Springs Capital Management LP | 154,500 | $1.54M |
| Cowen and Company, LLC | 62,475 | $622.0K |
| Glazer Capital, LLC | 58,541 | $577.0K |
| Exos Asset Management LLC | 25,100 | $250.0K |
| Janus Henderson Group PLC | 15,168 | $150.0K |